PDB Short entry for 2BAN HEADER TRANSFERASE 14-OCT-05 2BAN TITLE CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TITLE 2 JANSSEN-R157208 COMPND MOL_ID: 1; COMPND 2 MOLECULE: REVERSE TRANSCRIPTASE P66 SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 599-1158; COMPND 5 SYNONYM: HIV-1 RT; COMPND 6 EC: 2.7.7.49; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: REVERSE TRANSCRIPTASE P51 SUBUNIT; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: RESIDUES 599-1028; COMPND 13 SYNONYM: HIV-1 RT; COMPND 14 EC: 2.7.7.49; COMPND 15 ENGINEERED: YES; COMPND 16 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 STRAIN: BH10 ISOLATE; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 OTHER_DETAILS: HIV-1 CLONE 12; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 10 ORGANISM_TAXID: 11676; SOURCE 11 STRAIN: BH10 ISOLATE; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 14 OTHER_DETAILS: HIV-1 CLONE 12 KEYWDS AIDS, HIV, DRUG DESIGN, REVERSE TRANSCRIPTASE, RT, PROTEIN-INHIBITOR KEYWDS 2 COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.DAS,E.ARNOLD REVDAT 5 23-AUG-23 2BAN 1 REMARK REVDAT 4 20-OCT-21 2BAN 1 REMARK SEQADV LINK REVDAT 3 11-OCT-17 2BAN 1 REMARK REVDAT 2 24-FEB-09 2BAN 1 VERSN REVDAT 1 06-DEC-05 2BAN 0 JRNL AUTH D.M.HIMMEL,K.DAS,A.D.CLARK JR.,S.H.HUGHES,A.BENJAHAD, JRNL AUTH 2 S.OUMOUCH,J.GUILLEMONT,S.COUPA,A.PONCELET,I.CSOKA,C.MEYER, JRNL AUTH 3 K.ANDRIES,C.H.NGUYEN,D.S.GRIERSON,E.ARNOLD JRNL TITL CRYSTAL STRUCTURES FOR HIV-1 REVERSE TRANSCRIPTASE IN JRNL TITL 2 COMPLEXES WITH THREE PYRIDINONE DERIVATIVES: A NEW CLASS OF JRNL TITL 3 NON-NUCLEOSIDE INHIBITORS EFFECTIVE AGAINST A BROAD RANGE OF JRNL TITL 4 DRUG-RESISTANT STRAINS. JRNL REF J.MED.CHEM. V. 48 7582 2005 JRNL REFN ISSN 0022-2623 JRNL PMID 16302798 JRNL DOI 10.1021/JM0500323 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.BENJAHAD,M.CROISY,C.MONNERET,E.BISAGNI,D.MABIRE,S.COUPA, REMARK 1 AUTH 2 A.PONCELET,I.CSOKA,J.GUILLEMONT,C.MEYER,K.ANDRIES,R.PAUWELS, REMARK 1 AUTH 3 M.P.DE BETHUNE,D.M.HIMMEL,K.DAS,E.ARNOLD,C.H.NGUYEN, REMARK 1 AUTH 4 D.S.GRIERSON REMARK 1 TITL 4-BENZYL AND 4-BENZOYL-3-DIMETHYLAMINOPYRIDIN-2(1H)-ONES: IN REMARK 1 TITL 2 VITRO EVALUATION OF NEW C-3-AMINO-SUBSTITUTED AND REMARK 1 TITL 3 C-5,6-ALKYL-SUBSTITUTED ANALOGUES AGAINST CLINICALLY REMARK 1 TITL 4 IMPORTANT HIV MUTANT STRAINS REMARK 1 REF J.MED.CHEM. V. 48 1948 2005 REMARK 1 REFN ISSN 0022-2623 REMARK 1 REFERENCE 2 REMARK 1 AUTH K.DAS,A.D.CLARK JR.,P.J.LEWI,J.HEERES,M.R.DE JONGE, REMARK 1 AUTH 2 L.M.H.KOYMANS,H.M.VINKERS,F.DAEYAERT,D.W.LUDOVICI,M.J.KUKLA, REMARK 1 AUTH 3 B.DE CORTE,R.W.KAVASH,C.Y.HO,H.YE,M.A.LICHTENSTEIN, REMARK 1 AUTH 4 K.ANDRIES,R.PAUWELS,M.-P.DE BETHUNE,P.L.BOYER,P.CLARK, REMARK 1 AUTH 5 S.H.HUGHES,P.A.J.JANSSEN,E.ARNOLD REMARK 1 TITL ROLES OF CONFORMATIONAL AND POSITIONAL ADAPTABILITY IN REMARK 1 TITL 2 STRUCTURE-BASED DESIGN OF TMC125-R165335 (ETRAVIRINE) AND REMARK 1 TITL 3 RELATED NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS THAT REMARK 1 TITL 4 ARE HIGHLY POTENT AND EFFECTIVE AGAINST WILD-TYPE AND REMARK 1 TITL 5 DRUG-RESISTANT HIV-1 VARIANTS REMARK 1 REF J.MED.CHEM. V. 47 2550 2004 REMARK 1 REFN ISSN 0022-2623 REMARK 1 REFERENCE 3 REMARK 1 AUTH K.DAS,J.DING,Y.HSIOU,A.D.CLARK JR.,H.MOEREELS,L.KOYMANS, REMARK 1 AUTH 2 K.ANDRIES,R.PAUWELS,P.A.JANSSEN,P.L.BOYER,P.CLARK, REMARK 1 AUTH 3 R.H.SMITH JR.,M.B.KROEGER SMITH,C.J.MICHEJDA,S.H.HUGHES, REMARK 1 AUTH 4 E.ARNOLD REMARK 1 TITL CRYSTAL STRUCTURES OF 8-CL AND 9-CL TIBO COMPLEXED WITH REMARK 1 TITL 2 WILD-TYPE HIV-1 RT AND 8-CL TIBO COMPLEXED WITH THE REMARK 1 TITL 3 TYR181CYS HIV-1 RT DRUG-RESISTANT MUTANT. REMARK 1 REF J.MOL.BIOL. V. 264 1085 1996 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 4 REMARK 1 AUTH J.DING,K.DAS,Y.HSIOU,S.G.SARAFIANOS,A.D.CLARK JR., REMARK 1 AUTH 2 A.JACOBO-MOLINA,C.TANTILLO,S.H.HUGHES,E.ARNOLD REMARK 1 TITL STRUCTURE AND FUNCTIONAL IMPLICATIONS OF THE POLYMERASE REMARK 1 TITL 2 ACTIVE SITE REGION IN A COMPLEX OF HIV-1 RT WITH A REMARK 1 TITL 3 DOUBLE-STRANDED DNA TEMPLATE-PRIMER AND AN ANTIBODY FAB REMARK 1 TITL 4 FRAGMENT AT 2.8 A RESOLUTION. REMARK 1 REF J.MOL.BIOL. V. 284 1095 1998 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 5 REMARK 1 AUTH J.DING,K.DAS,H.MOEREELS,L.KOYMANS,K.ANDRIES,P.A.J.JANSSEN, REMARK 1 AUTH 2 S.H.HUGHES,E.ARNOLD REMARK 1 TITL STRUCTURE OF HIV-1 RT/TIBO R 86183 COMPLEX REVEALS REMARK 1 TITL 2 SIMILARITY IN THE BINDING OF DIVERSE NONNUCLEOSIDE REMARK 1 TITL 3 INHIBITORS. REMARK 1 REF NAT.STRUCT.BIOL. V. 2 407 1995 REMARK 1 REFN ISSN 1072-8368 REMARK 2 REMARK 2 RESOLUTION. 2.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.86 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 382406.531 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.9 REMARK 3 NUMBER OF REFLECTIONS : 30359 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.243 REMARK 3 FREE R VALUE : 0.305 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1499 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 71.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3703 REMARK 3 BIN R VALUE (WORKING SET) : 0.4540 REMARK 3 BIN FREE R VALUE : 0.4990 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 199 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.035 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7896 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 25 REMARK 3 SOLVENT ATOMS : 1 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 14.57000 REMARK 3 B22 (A**2) : -16.71000 REMARK 3 B33 (A**2) : 2.15000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 35.40000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.48 REMARK 3 ESD FROM SIGMAA (A) : 0.91 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.61 REMARK 3 ESD FROM C-V SIGMAA (A) : 1.11 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.700 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.070 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.340 ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.940 ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : 2.840 ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.650 ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.23 REMARK 3 BSOL : 14.90 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN.TOP REMARK 3 PARAMETER FILE 2 : ION.TOP REMARK 3 PARAMETER FILE 3 : WATER.TOP REMARK 3 PARAMETER FILE 4 : 157.TOP REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN_REP.PARAM REMARK 3 TOPOLOGY FILE 2 : ION.PARAM REMARK 3 TOPOLOGY FILE 3 : WATER_REP.PARAM REMARK 3 TOPOLOGY FILE 4 : 157.PAR REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2BAN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-OCT-05. REMARK 100 THE DEPOSITION ID IS D_1000034882. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-FEB-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 14-BM-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31625 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.950 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.06 REMARK 200 COMPLETENESS FOR SHELL (%) : 77.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.40400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1HNV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG8000, AMMINIUM SULPHATE, SODIUM, REMARK 280 CHLORID, MANGANESE CHLORIDE, PH 6.8, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 113.12000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.71500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 113.12000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 34.71500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5520 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 47250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 553 REMARK 465 ALA A 554 REMARK 465 GLY A 555 REMARK 465 ILE A 556 REMARK 465 ARG A 557 REMARK 465 LYS A 558 REMARK 465 ILE A 559 REMARK 465 LEU A 560 REMARK 465 GLN B 428 REMARK 465 LEU B 429 REMARK 465 GLU B 430 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 31 CG1 CG2 CD1 REMARK 470 LYS A 70 CG CD CE NZ REMARK 470 TRP A 71 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 71 CZ3 CH2 REMARK 470 ARG A 72 CG CD NE CZ NH1 NH2 REMARK 470 SER A 134 OG REMARK 470 ILE A 135 CG1 CG2 CD1 REMARK 470 THR A 139 OG1 CG2 REMARK 470 LYS A 220 CG CD CE NZ REMARK 470 HIS A 221 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 222 CG CD OE1 NE2 REMARK 470 LYS A 287 CG CD CE NZ REMARK 470 LEU A 289 CG CD1 CD2 REMARK 470 VAL A 292 CG1 CG2 REMARK 470 ILE A 293 CG1 CG2 CD1 REMARK 470 LYS A 323 CG CD CE NZ REMARK 470 ARG A 356 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 366 CG CD CE NZ REMARK 470 LYS B 13 CG CD CE NZ REMARK 470 GLN B 197 CG CD OE1 NE2 REMARK 470 ARG B 199 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 220 CG CD CE NZ REMARK 470 GLN B 222 CG CD OE1 NE2 REMARK 470 LYS B 223 CG CD CE NZ REMARK 470 GLU B 224 CG CD OE1 OE2 REMARK 470 PHE B 227 CG CD1 CD2 CE1 CE2 CZ REMARK 470 TRP B 229 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 229 CZ3 CH2 REMARK 470 MET B 230 CG SD CE REMARK 470 ILE B 270 CG1 CG2 CD1 REMARK 470 ARG B 358 CG CD NE CZ NH1 NH2 REMARK 470 HIS B 361 CG ND1 CD2 CE1 NE2 REMARK 470 THR B 362 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ARG B 125 N TYR B 127 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 25 C - N - CA ANGL. DEV. = 9.9 DEGREES REMARK 500 LEU A 26 N - CA - C ANGL. DEV. = 20.6 DEGREES REMARK 500 PRO A 55 C - N - CA ANGL. DEV. = 11.2 DEGREES REMARK 500 PRO A 55 N - CA - C ANGL. DEV. = 28.4 DEGREES REMARK 500 PRO A 133 C - N - CA ANGL. DEV. = 9.9 DEGREES REMARK 500 PRO B 95 C - N - CA ANGL. DEV. = 10.7 DEGREES REMARK 500 PRO B 272 C - N - CA ANGL. DEV. = 9.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 13 157.29 -37.63 REMARK 500 MET A 16 162.16 -44.76 REMARK 500 LEU A 26 -64.59 -142.05 REMARK 500 GLU A 28 -73.64 -9.78 REMARK 500 GLU A 44 3.59 -68.42 REMARK 500 ASN A 54 -79.43 -92.19 REMARK 500 PRO A 55 -174.50 -61.92 REMARK 500 LYS A 65 -29.02 -149.29 REMARK 500 LYS A 66 -160.78 -60.03 REMARK 500 ASP A 67 29.86 -74.10 REMARK 500 LYS A 70 149.94 169.25 REMARK 500 GLU A 79 0.56 -69.54 REMARK 500 GLN A 85 157.64 -49.84 REMARK 500 GLU A 89 115.59 -31.17 REMARK 500 VAL A 90 -87.72 -58.30 REMARK 500 LEU A 92 -78.86 -49.66 REMARK 500 ASP A 113 14.32 -67.87 REMARK 500 ALA A 114 -87.39 -12.09 REMARK 500 ASP A 121 123.31 -36.23 REMARK 500 PRO A 133 172.67 -52.97 REMARK 500 ASN A 136 -69.37 -154.40 REMARK 500 VAL A 148 -167.12 -115.64 REMARK 500 GLN A 151 -18.02 -43.37 REMARK 500 LYS A 154 -70.59 -39.17 REMARK 500 ALA A 158 -70.67 -48.85 REMARK 500 PHE A 160 -71.45 -71.35 REMARK 500 ASN A 175 62.86 -151.90 REMARK 500 PRO A 176 29.33 -61.47 REMARK 500 MET A 184 -103.08 63.51 REMARK 500 ILE A 195 -22.64 -34.74 REMARK 500 LYS A 219 27.87 -75.29 REMARK 500 LYS A 220 -11.28 55.71 REMARK 500 GLN A 222 28.66 -159.82 REMARK 500 GLU A 224 59.04 -116.35 REMARK 500 MET A 230 30.80 39.68 REMARK 500 ASP A 237 14.15 -146.17 REMARK 500 THR A 240 -144.57 -167.63 REMARK 500 VAL A 241 43.77 -155.64 REMARK 500 GLN A 242 -75.51 -12.06 REMARK 500 PRO A 243 70.18 -59.99 REMARK 500 ILE A 244 70.94 -115.70 REMARK 500 LYS A 249 -163.44 -161.78 REMARK 500 ASN A 255 -72.43 -59.82 REMARK 500 PRO A 272 108.53 -44.13 REMARK 500 ILE A 274 142.15 -35.50 REMARK 500 VAL A 276 2.97 -158.36 REMARK 500 LYS A 281 -36.53 -36.92 REMARK 500 ARG A 284 143.09 -39.26 REMARK 500 LYS A 287 39.37 -150.38 REMARK 500 LEU A 289 28.62 -67.56 REMARK 500 REMARK 500 THIS ENTRY HAS 144 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR B 232 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN A 561 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 443 OD1 REMARK 620 2 GLU A 478 OE2 79.0 REMARK 620 3 ASP A 498 OD2 81.4 94.9 REMARK 620 4 HOH A1001 O 96.1 169.7 75.3 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MN A 561 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 357 A 562 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2B5J RELATED DB: PDB REMARK 900 RELATED ID: 1S6Q RELATED DB: PDB REMARK 900 RELATED ID: 1SV5 RELATED DB: PDB REMARK 900 RELATED ID: 1S6P RELATED DB: PDB REMARK 900 RELATED ID: 2BE2 RELATED DB: PDB DBREF 2BAN A 1 560 UNP P03366 POL_HV1B1 599 1158 DBREF 2BAN B 1 430 UNP P03366 POL_HV1B1 599 1028 SEQADV 2BAN SER A 280 UNP P03366 CYS 878 ENGINEERED MUTATION SEQADV 2BAN SER B 280 UNP P03366 CYS 878 ENGINEERED MUTATION SEQRES 1 A 560 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 A 560 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 A 560 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 A 560 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 A 560 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 A 560 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 A 560 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 A 560 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 A 560 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 A 560 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 A 560 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 A 560 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 A 560 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 A 560 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 A 560 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 A 560 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 A 560 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 A 560 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 A 560 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 A 560 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 A 560 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 A 560 ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG GLY THR SEQRES 23 A 560 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 A 560 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 A 560 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 A 560 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 A 560 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 A 560 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 A 560 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 A 560 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 A 560 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 A 560 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 A 560 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 A 560 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE TYR VAL SEQRES 35 A 560 ASP GLY ALA ALA ASN ARG GLU THR LYS LEU GLY LYS ALA SEQRES 36 A 560 GLY TYR VAL THR ASN LYS GLY ARG GLN LYS VAL VAL PRO SEQRES 37 A 560 LEU THR ASN THR THR ASN GLN LYS THR GLU LEU GLN ALA SEQRES 38 A 560 ILE TYR LEU ALA LEU GLN ASP SER GLY LEU GLU VAL ASN SEQRES 39 A 560 ILE VAL THR ASP SER GLN TYR ALA LEU GLY ILE ILE GLN SEQRES 40 A 560 ALA GLN PRO ASP LYS SER GLU SER GLU LEU VAL ASN GLN SEQRES 41 A 560 ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL TYR LEU SEQRES 42 A 560 ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY GLY ASN GLU SEQRES 43 A 560 GLN VAL ASP LYS LEU VAL SER ALA GLY ILE ARG LYS ILE SEQRES 44 A 560 LEU SEQRES 1 B 430 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 B 430 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 B 430 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 B 430 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 B 430 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 B 430 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 B 430 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 B 430 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 B 430 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 B 430 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 B 430 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 B 430 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 B 430 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 B 430 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 B 430 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 B 430 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 B 430 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 B 430 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 B 430 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 B 430 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 B 430 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 B 430 ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG GLY THR SEQRES 23 B 430 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 B 430 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 B 430 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 B 430 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 B 430 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 B 430 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 B 430 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 B 430 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 B 430 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 B 430 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 B 430 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 B 430 GLU HET MN A 561 1 HET 357 A 562 24 HETNAM MN MANGANESE (II) ION HETNAM 357 5-ETHYL-3-[(2-METHOXYETHYL)METHYLAMINO]-6-METHYL-4-(3- HETNAM 2 357 METHYLBENZYL)PYRIDIN-2(1H)-ONE FORMUL 3 MN MN 2+ FORMUL 4 357 C20 H28 N2 O2 FORMUL 5 HOH *(H2 O) HELIX 1 1 GLU A 29 GLU A 42 1 14 HELIX 2 2 PHE A 77 LYS A 82 1 6 HELIX 3 3 HIS A 96 LEU A 100 5 5 HELIX 4 4 ASP A 113 VAL A 118 1 6 HELIX 5 5 ASP A 121 ALA A 129 5 9 HELIX 6 6 SER A 156 ASN A 175 1 20 HELIX 7 7 GLU A 194 ARG A 211 1 18 HELIX 8 8 VAL A 254 GLN A 269 1 16 HELIX 9 9 THR A 296 GLU A 312 1 17 HELIX 10 10 ASN A 363 GLY A 384 1 22 HELIX 11 11 GLN A 394 TYR A 405 1 12 HELIX 12 12 THR A 473 SER A 489 1 17 HELIX 13 13 SER A 499 ALA A 508 1 10 HELIX 14 14 SER A 515 LYS A 528 1 14 HELIX 15 15 GLY A 544 ASP A 549 1 6 HELIX 16 16 THR B 27 GLU B 42 1 16 HELIX 17 17 PHE B 77 ARG B 83 1 7 HELIX 18 18 THR B 84 TRP B 88 5 5 HELIX 19 19 GLY B 112 VAL B 118 5 7 HELIX 20 20 ASP B 121 LYS B 126 1 6 HELIX 21 21 SER B 134 GLU B 138 5 5 HELIX 22 22 GLY B 155 LEU B 168 1 14 HELIX 23 23 LEU B 168 LYS B 173 1 6 HELIX 24 24 GLU B 194 LEU B 214 1 21 HELIX 25 25 HIS B 235 TRP B 239 5 5 HELIX 26 26 VAL B 254 SER B 268 1 15 HELIX 27 27 SER B 280 ARG B 284 5 5 HELIX 28 28 THR B 296 LEU B 310 1 15 HELIX 29 29 ASN B 363 TRP B 383 1 21 HELIX 30 30 GLN B 394 TRP B 406 1 13 HELIX 31 31 PRO B 421 LEU B 425 5 5 SHEET 1 A 3 ILE A 47 LYS A 49 0 SHEET 2 A 3 ILE A 142 TYR A 146 -1 O GLN A 145 N SER A 48 SHEET 3 A 3 PHE A 130 ILE A 132 -1 N ILE A 132 O ILE A 142 SHEET 1 B 2 VAL A 60 ILE A 63 0 SHEET 2 B 2 ARG A 72 VAL A 75 -1 O LEU A 74 N PHE A 61 SHEET 1 C 3 SER A 105 ASP A 110 0 SHEET 2 C 3 ASP A 186 SER A 191 -1 O LEU A 187 N LEU A 109 SHEET 3 C 3 VAL A 179 TYR A 183 -1 N TYR A 181 O TYR A 188 SHEET 1 D 3 PHE A 227 TRP A 229 0 SHEET 2 D 3 TYR A 232 LEU A 234 -1 O LEU A 234 N PHE A 227 SHEET 3 D 3 TRP A 239 THR A 240 -1 O THR A 240 N GLU A 233 SHEET 1 E 2 TRP A 252 THR A 253 0 SHEET 2 E 2 VAL A 292 ILE A 293 -1 O ILE A 293 N TRP A 252 SHEET 1 F 5 LYS A 350 ALA A 355 0 SHEET 2 F 5 GLN A 336 TYR A 342 -1 N ILE A 341 O LYS A 350 SHEET 3 F 5 ILE A 326 LYS A 331 -1 N GLN A 330 O THR A 338 SHEET 4 F 5 LYS A 388 LEU A 391 1 O LYS A 388 N ALA A 327 SHEET 5 F 5 TRP A 414 PHE A 416 1 O GLU A 415 N LEU A 391 SHEET 1 G 5 GLN A 464 THR A 470 0 SHEET 2 G 5 LEU A 452 THR A 459 -1 N GLY A 453 O LEU A 469 SHEET 3 G 5 THR A 439 ALA A 446 -1 N ALA A 445 O LYS A 454 SHEET 4 G 5 GLU A 492 THR A 497 1 O ASN A 494 N PHE A 440 SHEET 5 G 5 LYS A 530 TRP A 535 1 O TYR A 532 N ILE A 495 SHEET 1 H 3 ILE B 47 LYS B 49 0 SHEET 2 H 3 ILE B 142 TYR B 146 -1 O GLN B 145 N SER B 48 SHEET 3 H 3 PHE B 130 ILE B 132 -1 N PHE B 130 O TYR B 144 SHEET 1 I 2 VAL B 60 ILE B 63 0 SHEET 2 I 2 ARG B 72 VAL B 75 -1 O LEU B 74 N PHE B 61 SHEET 1 J 4 VAL B 179 TYR B 183 0 SHEET 2 J 4 ASP B 186 SER B 191 -1 O TYR B 188 N TYR B 181 SHEET 3 J 4 SER B 105 ASP B 110 -1 N SER B 105 O SER B 191 SHEET 4 J 4 GLU B 233 LEU B 234 -1 O LEU B 234 N VAL B 106 SHEET 1 K 2 TRP B 252 THR B 253 0 SHEET 2 K 2 VAL B 292 ILE B 293 -1 O ILE B 293 N TRP B 252 SHEET 1 L 5 ASN B 348 TYR B 354 0 SHEET 2 L 5 TRP B 337 TYR B 342 -1 N TRP B 337 O TYR B 354 SHEET 3 L 5 ILE B 326 LYS B 331 -1 N ILE B 326 O TYR B 342 SHEET 4 L 5 LYS B 388 LEU B 391 1 O LYS B 390 N ALA B 327 SHEET 5 L 5 GLU B 413 PHE B 416 1 O GLU B 415 N PHE B 389 LINK OD1 ASP A 443 MN MN A 561 1555 1555 2.03 LINK OE2 GLU A 478 MN MN A 561 1555 1555 2.39 LINK OD2 ASP A 498 MN MN A 561 1555 1555 2.18 LINK MN MN A 561 O HOH A1001 1555 1555 2.48 CISPEP 1 PRO A 225 PRO A 226 0 0.09 CISPEP 2 PRO A 420 PRO A 421 0 -0.16 SITE 1 AC1 5 ASP A 443 GLY A 444 GLU A 478 ASP A 498 SITE 2 AC1 5 HOH A1001 SITE 1 AC2 12 PRO A 95 LEU A 100 LYS A 101 LYS A 103 SITE 2 AC2 12 VAL A 179 TYR A 181 TYR A 188 GLY A 190 SITE 3 AC2 12 TRP A 229 LEU A 234 TYR A 318 GLU B 138 CRYST1 226.240 69.430 104.450 90.00 106.49 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004420 0.000000 0.001308 0.00000 SCALE2 0.000000 0.014403 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009985 0.00000